Evaluation of Effectiveness and Safety of Paliperidone Extended Release in Patients With Schizoaffective Disorder.

Clinical trial NCT00397033 · COMPLETED

Trial details

NCT number: NCT00397033
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Schizoaffective Disorder Psychotic Disorder

Start date: 2006-11-01
Primary completion: 2008-02-01
Enrollment: 316

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.